Showing 351-360 of 468 results for "".
- Crown CFO Nadeem Moiz to Take on COO Role Toohttps://modernaesthetics.com/news/crown-cfo-nadeem-moiz-to-take-on-coo-role-too/2473264/Crown Laboratories Chief Financial Officer (CFO) Nadeem Moiz will take on expanded responsibilities as Chief Operations Officer (COO). This appointment is made as Jack Songster, Crown's current COO, is set to retire on July 15. In this dual role, Mr. Moiz w
- FDA Nod for Sientra’s Low Plus Profile Projection Breast Implanthttps://modernaesthetics.com/news/fda-nod-for-sientras-low-plus-profile-projection-breast-implant-1/2473263/The U.S. Food and Drug Administration (FDA) approved Sientra’s Low Plus Profile Projection Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction. This product will be commercially available for board-certi
- Cynosure Launches Innovative Tempsure eyeEnvi Handpiece with Improved Function and Greater Comforthttps://modernaesthetics.com/news/cynosure-launches-innovative-tempsure-eyeenvi-handpiece-with-improved-function-and-greater-comfort/2473262/Cynosure's new Tempsure eyeEnvi handpiece features innovative ergonomic pencil grip design and lighter piston tension required to activate the treatment, making it more comfortable for both patient and provider, heating thinner tissue more effectively and comfortably while minimizin
- Top-line Phase 3 Data Promising for Galderma's RelabotulinumtoxinAhttps://modernaesthetics.com/news/top-line-phase-3-data-promising-for-galdermas-relabotulinumtoxina/2473250/Galderma’s investigational RelabotulinumtoxinA, a novel liquid formulation botulinum toxin A, improves both glabellar and lateral canthal lines with a rapid onset of action and a long duration up to six months, according to top-line phase 3 data presen
- Cynosure Rolls Out PicoSure Pro Devicehttps://modernaesthetics.com/news/cynosure-rolls-out-picosure-pro-device/2473248/Cynosure is launching the PicoSure Pro device, the latest upgrade to the company's PicoSure system. The FDA-cleared 755nm picosecond laser on the market, the PicoSure Pro device uniquely delivers energy in a trillionth of a second, utilizing pressure instead of heat to provide
- IT Cosmetics Launches Confidence at Work Initiativehttps://modernaesthetics.com/news/it-cosmetics-launches-confidence-at-work-initiative/2473247/IT Cosmetics is launching Confidence at Work, an initiative that aims to bring awareness to the confidence crisis affecting women at work. The Founder of The American Confidence Institute, Alyssa Dver, will serve as the brand's official Confidence Educator.
- Apyx Medical Corporation Scores FDA 510(k) Clearance for Renuvion Handpiecehttps://modernaesthetics.com/news/apyx-medical-corporation-scores-fda-510k-clearance-for-renuvion-handpiece/2473245/The U.S. Food and Drug Administration has granted marketing clearance to Apyx Medical Corporation’s Renuvion Dermal Handpiece for specific dermal resurfacing procedures. The Renuvion Dermal Handpiece is indicated for dermatological procedures for the treatment of moderate to
- Merz Aesthetics Partners with North Carolina Courage, Reigning NWSL Challenge Cup Championshttps://modernaesthetics.com/news/merz-aesthetics-partners-with-north-carolina-courage-reigning-nwsl-challenge-cup-champions/2473240/In a new partnership with the North Carolina Courage, reigning NWSL Challenge Cup Champions and two-time champions of the National Women’s Soccer League (NWSL), Merz Aesthetics aims to promote confidence, character, and sportsmanship. The partnership, kicking off Sunday, includes
- Cynosure Receives $60 Million Follow-on Investment from Clayton, Dubilier & Ricehttps://modernaesthetics.com/news/cynosure-recieves-60-million-follow-on-investment-from-clayton-dubilier-rice/2473237/Cynosure, LLC, received $60 million from lead investor Clayton, Dubilier & Rice. The new capital supports the company's plans to continue investing ahead of strong growth to bring innovation to the market and provide comprehensive treatment solutions to its cust
- Coming This Week: Cutera AviClear Webinarhttps://modernaesthetics.com/news/coming-this-week-cutera-aviclear-webinar/2473230/Cutera hosts the first webinar for AviClear, the first and only FDA cleared energy-based device for the treatment of mild, moderate, and severe acne, this week. Dermatologists Jeffrey S. Dover, MD, FRCPC and Julie C. Harper, MD will discuss the latest advancement in the treatment of acn